We are monitoring the impact of COVID-19 on APAC Nuclear Imaging Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1546
Share on
Share on

APAC Nuclear Imaging Market Research Report – Segmented By Diagnostic Technologies, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 1546
Pages: 138

APAC Nuclear Imaging Market Size & Growth (2019 - 2024)

The size of the Nuclear Imaging Market in the Asia Pacific was worth USD 3.71 billion in 2019 and estimated to be growing at a CAGR of 9.64%, to reach USD 5.88 billion by 2024.

Medical imaging is the method of generating a photographic image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.

Nuclear imaging is most commonly utilized for cardiovascular and oncology applications. It refers to the method of generating visuals of the organs of the body by processing a minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer.

The growth of the Asia-Pacific Nuclear Imaging market is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, predilection towards minimally invasive procedures, the ready availability of radiopharmaceuticals, and improving healthcare infrastructure in developing markets.

However, factors such as costly procedures & equipment, inadequate number of trained medical staff, and shortage of supplies are hampering the growth of the market in this region.

This research report has been segmented & sub-segmented into the following categories:

  • By Application: Oncology, Cardiology, Neurology and Others
  • By Product: Standalone PET Nuclear Imaging, Standalone SPECT Nuclear Imaging and Hybrid Nuclear Imaging
  • By End-User: Hospitals, Diagnostic Centers and Research Centers
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Among Asia-Pacific countries, India, Japan, and Australia will be the substantial markets due to growing healthcare budgets and the rising popularity of several radiopharmaceuticals in numerous clinical indications.

The major companies dominating the APAC Nuclear Imaging market in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Technologies                        

                                5.1.1 Introduction           

                                5.1.2 PET Radioisotopes

                                                5.1.2.1 Rubidium-82

                                                5.1.2.2 Fluorine-18

                                                5.1.2.3 Others

                                5.1.3 SPECT Radioisotopes          

                                                5.1.3.1 Thallium-201

                                                5.1.3.2 Technetium-99m

                                                5.1.3.3 Xenon-133

                                                5.1.3.4 Iodine-123

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies                

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies              

                                5.1.6 Market Share Analysis, By Diagnostic Technologies               

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PET             

                                                5.2.2.1 Cardiology

                                                5.2.2.2 Oncology

                                                5.2.2.3 Neurology

                                                5.2.2.4 Others

                                5.2.3 SPECT        

                                                5.2.3.1 Lymphoma

                                                5.2.3.2 Neurology

                                                5.2.3.3 Cardiology

                                                5.2.3.4 Thyroid

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application        

                                5.2.6 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technologies

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technologies

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technologies

                                                6.1.5.3 By Application

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Mallinckrodt plc                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens Medical Solutions                  

                8.3 Hitachi Medical Corporation               

                8.4 Medtronic Inc.                          

                8.5 General Electric Co. (healthcare division)                       

                8.6 IBA Group                   

                8.7 Positron Corporation                              

                8.8 Philips Medical Systems                        

                8.9 Naviscan                      

                8.10 Toshiba Medical Systems Corporation                          

                8.11 Carestream Health                

                8.12 Lantheus Medical Imaging Inc.                         

                8.13 Cardinal Health Inc.                              

                8.14 Bayer AG                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Nuclear Imaging Market By Region, From 2019 - 2024 (USD Billion)
  2. Asia-Pacific Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  3. Asia-Pacific PET Radioisotopes Market By Region, From 2019 - 2024 (USD Billion)
  4. Asia-Pacific Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  5. Asia-Pacific Rubidium-82 Market By Region, From 2019 - 2024 (USD Billion)
  6. Asia-Pacific Fluorine-18 Market By Region, From 2019 - 2024 (USD Billion)
  7. Asia-Pacific Other PET radioisotopes Market By Region, From 2019 - 2024 (USD Billion)
  8. Asia-Pacific SPECT Radioisotopes Market By Region, From 2019 - 2024 (USD Billion)
  9. Asia-Pacific Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  10. Asia-Pacific Thallium-201 Market By Region, From 2019 - 2024 (USD Billion)
  11. Asia-Pacific Technetium-99m Market By Region, From 2019 - 2024 (USD Billion)
  12. Asia-Pacific Xenon-133 Market By Region, From 2019 - 2024 (USD Billion)
  13. Asia-Pacific Iodine-123 Market By Region, From 2019 - 2024 (USD Billion)
  14. Asia-Pacific Other SPECT radioisotopes Market By Region, From 2019 - 2024 (USD Billion)
  15. Asia-Pacific Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  16. Asia-Pacific PET Market By Region, From 2019 - 2024 (USD Billion)
  17. Asia-Pacific Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  18. Asia-Pacific Cardiology Market By Region, From 2019 - 2024 (USD Billion)
  19. Asia-Pacific Oncology Market By Region, From 2019 - 2024 (USD Billion)
  20. Asia-Pacific Neurology Market By Region, From 2019 - 2024 (USD Billion)
  21. Asia-Pacific Other PET applications Market By Region, From 2019 - 2024 (USD Billion)
  22. Asia-Pacific SPECT Market By Region, From 2019 - 2024 (USD Billion)
  23. Asia-Pacific Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)
  24. Asia-Pacific Lymphoma Market By Region, From 2019 - 2024 (USD Billion)
  25. Asia-Pacific Neurology Market By Region, From 2019 - 2024 (USD Billion)
  26. Asia-Pacific Cardiology Market By Region, From 2019 - 2024 (USD Billion)
  27. Asia-Pacific Thyroid Market By Region, From 2019 - 2024 (USD Billion)
  28. Asia-Pacific Other SPECT applications Market By Region, From 2019 - 2024 (USD Billion)
  29. China Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  30. China Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  31. China Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  32. China Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  33. China Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  34. China Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)
  35. India Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  36. India Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  37. India Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  38. India Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  39. India Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  40. India Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)
  41. Japan Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  42. Japan Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  43. Japan Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  44. Japan Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  45. Japan Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  46. Japan Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)
  47. South Korea Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  48. South Korea Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  49. South Korea Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  50. South Korea Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  51. South Korea Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  52. South Korea Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)
  53. Australia Nuclear Imaging Market By Diagnostic Technologies , From 2019 - 2024 (USD Billion)
  54. Australia Nuclear Imaging Market By PET Radioisotopes, From 2019 - 2024 (USD Billion)
  55. Australia Nuclear Imaging Market By SPECT Radioisotopes, From 2019 - 2024 (USD Billion)
  56. Australia Nuclear Imaging Market By Application, From 2019 - 2024 (USD Billion)
  57. Australia Nuclear Imaging Market By PET, From 2019 - 2024 (USD Billion)
  58. Australia Nuclear Imaging Market By SPECT, From 2019 - 2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample